RNA β€” Avidity Biosciences Inc

Ownership history in Sofinnova Investments, Inc.  Β·  7 quarters on record

This page tracks every 13F SEC filing in which Sofinnova Investments, Inc. reported a position in Avidity Biosciences Inc (RNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
2.32% (2025 Q4)
πŸ“Š Avg. % of fund
0.91%
πŸ“… First filed
2024 Q2
πŸ“… Last filed
2025 Q4
⏱ Quarters held
7
% of Fund (quarterly)    RNA price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 7 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 745,116 -130,809 -14.9% 2.32% $53.7M β€”
2025 Q3 ADDED 875,925 +291,124 +49.8% 2.09% $38.2M β€”
2025 Q2 ADDED 584,801 +204,870 +53.9% 1.02% $16.6M β€”
2025 Q1 ADDED 379,931 +366,142 +2655.3% 0.73% $11.2M β€”
2024 Q4 REDUCED 13,789 -16,683 -54.7% 0.03% $401K β€”
2024 Q3 ADDED 30,472 +9,047 +42.2% 0.11% $1.4M β€”
2024 Q2 INITIATED 21,425 β€” β€” 0.05% $875K β€”
← Back to Sofinnova Investments, Inc. Holdings